Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination insufficient myelination or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome or a pharmaceutically acceptable salt thereof.